These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 237777)

  • 1. Monoamine oxidase inhibitors antagonize the acceleration of brain dopamine synthesis induced by neuroleptic drugs in vivo: implications for the treatment of Tardive dyskinesia.
    Koe BK
    Experientia; 1975 Jun; 31(6):669-71. PubMed ID: 237777
    [No Abstract]   [Full Text] [Related]  

  • 2. Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the rat.
    Javoy F; Youdim MB; Agid Y; Glowinski J
    J Neural Transm; 1973; 34(4):279-89. PubMed ID: 4149516
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of psychoactive drugs on in vivo metabolism of 14C-histamine in mouse brain.
    Schayer RW; Reilly MA
    Arch Int Pharmacodyn Ther; 1973 May; 203(1):123-9. PubMed ID: 4725329
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo studies on the effect of monoamine oxidase inhibitors on dopamine and serotonin metabolism in rat brain areas.
    Clement HW; Grote C; Wesemann W
    J Neural Transm Suppl; 1990; 32():85-8. PubMed ID: 2128514
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB; Angers M
    Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of monoamine oxidase inhibitors on 5-hydroxytryptamine synthesis in the brain.
    Weber LJ
    Proc Soc Exp Biol Med; 1966 Oct; 123(1):35-8. PubMed ID: 4380811
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid effects of monoamine oxidase inhibitors on synthesis and release of central monoamines.
    Glowinski J; Hamon M; Javoy F; Morot-Gaudry Y
    Adv Biochem Psychopharmacol; 1972; 5():423-39. PubMed ID: 4403372
    [No Abstract]   [Full Text] [Related]  

  • 8. On the selective inhibition by some monoamine oxidase inhibitors of deamination of biogenic monoamines in vivo.
    Gorkin VZ; Romanova LA
    Biochem Pharmacol; 1968 Jun; 17(6):855-60. PubMed ID: 5661349
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of L-3,5-[3H]-tyrosine and the measurement of tritiated water to estimate DA turnover in central dopaminergic terminals.
    Glowinski J
    Neuropharmacology; 1976 Oct; 15(10):585-90. PubMed ID: 11422
    [No Abstract]   [Full Text] [Related]  

  • 10. Short-term control of tyrosine hydroxylase.
    Carlsson A; Kehr W; Lindqvist M
    Adv Biochem Psychopharmacol; 1974; 12(0):135-42. PubMed ID: 4154020
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of action of vesicular monoamine transporter 2 (VMAT2) inhibitors in tardive dyskinesia: reducing dopamine leads to less "go" and more "stop" from the motor striatum for robust therapeutic effects.
    Stahl SM
    CNS Spectr; 2018 Feb; 23(1):1-6. PubMed ID: 29249207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Special application of fluorescence histochemistry: studies on eight monoamine oxidase inhibitors in brain neurons.
    Bartonícek VJ
    Pharmacology; 1970; 4(1):16-24. PubMed ID: 4393462
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Jul; 27(1):95-9. PubMed ID: 4555831
    [No Abstract]   [Full Text] [Related]  

  • 14. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of apomorphine, neuroleptics and stimulants with alpha-methyl-m-tyramine, a false dopaminergic transmitter.
    Dorris RL; Shore PA
    Biochem Pharmacol; 1974 Feb; 23(4):867-72. PubMed ID: 4150986
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of monoamine oxidase inhibitors of various chemical nature on some indices of carbohydrate metabolism in the rabbit brain].
    Musialkovskaia AA
    Ukr Biokhim Zh; 1967; 39(2):119-24. PubMed ID: 5603054
    [No Abstract]   [Full Text] [Related]  

  • 17. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.
    Burt DR; Creese I; Snyder SH
    Science; 1977 Apr; 196(4287):326-8. PubMed ID: 847477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible inhibition of monoamine oxidase.
    Planz G; Quiring K; Palm D
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):424-5. PubMed ID: 4253849
    [No Abstract]   [Full Text] [Related]  

  • 19. Feedback regulation of 5-HT synthesis in rat striatal slices.
    Hamon M; Bourgoin S; Glowinski J
    J Neurochem; 1973 Jun; 20(6):1727-45. PubMed ID: 4146316
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulation of insulin secretion in rats by pargyline and mebanazine.
    Frohman LA
    Diabetes; 1971 May; 20(5):266-70. PubMed ID: 5581314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.